I NT R O DU C T I ON
Poor compliance with antihypertensive drug treatment has often been associated with treatment failure or uncontrolled hypertension and disease progression (1) (2) (3) . Poor compliance has also been attributed to an increase in outpatient visits, unnecessary hospital admissions, and associated medical expenses (4, 5) . Although compliance with antihypertensive drug treatment has been recognized as essential to the clinical management of hypertension (6) (7) (8) , poor compliance with antihypertensive drug treatment is still widespread, especially among elderly patients (9) . Thus, to increase the effectiveness of medical care of hypertension and reduce unnecessary medical expenses associated with hypertension, it is important to improve compliance with antihypertensive drug treatment.
Previous studies have identified a number of factors associated with poor compliance with medications by the patients, including sociodemographic characteristics (such as age, race, education, and marital status), medical conditions (such as number of comorbid conditions and medications), and health care variables (such as satisfaction with health care and involvement in treatment decisions) (10) . Despite a number of studies addressing factors associated with poor compliance by the patients, these studies have found no clear consistent relationships linking patient characteristics to poor compliance with medication.
More recent work has begun to focus on health providers' characteristics in contributing to poor compliance by the patients (11, 12) . A number of studies have identified health providers' age and gender as two possible factors influencing patients' poor compliance with medication (13, 14) . However, while these previous studies tend to focus on physicians' sociodemographic characteristics, little attention has been given to the role of physicians' medical speciality or type of medical practice in influencing medication compliance by the patients.
In this study, we used a measure of compliance developed by prescriptions and refills from the computer-based pharmacy records within the Veterans Health Administration (VA) to identify both patient and physician characteristics that are associated with poor compliance with antihypertensive medications by the patients.
METH ODS

Sample
This study used prescription records from patients who were part of a larger project, the Veterans Health Study (VHS). The details of the VHS are described elsewhere (15) . Briefly, the VHS recruited patients who used ambulatory care services at one of the four VA outpatient clinics in the greater Boston area between June, 1993, and March 1996. A total of 7045 patients, who had at least one VA visit in the previous year, were approached by research staff, completed a brief screening questionnaire, and provided contact information. Of the 4137 eligible patients, 2425 (59%) agreed to participate. Comparisons with medical records data indicate that the VHS sample of patients is broadly representative of regular users of VA outpatient clinics in the greater Boston area.
Measures
All recruited patients were mailed a questionnaire that included the Veterans Short-Form Health Survey (SF-36), and all were scheduled for an inperson interview within a month at which time they completed a physical examination, clinical assessments, and a medical history. The Veterans SF-36, adopted from the Medical Outcomes Study Short Form Health Survey, is a self-reported assessment of functional status and well-being (16, 17) . The Veterans SF-36 items can be aggregated into two summary scales: physical (PCS) and mental component summary (MCS), each of which is scored using a linear t score transformation which is normed to a general U.S. population with a mean of 50 and SD of 10 (15, 18) .
Other measures of the VHS included patients' age, years of education (£12 vs. >12), marital status (married vs. not married), race (white vs. nonwhite), satisfaction with health care, ratings of the quality of care, number of comorbid conditions, self-reported compliance in terms of being careless or forgetful in taking medications, perceived amount of prescribed medications, and propensity to participate in treatment decisions. All these variables have been hypothesized in the literature to influence medication compliance by the patients (10, 19, 20) . Satisfaction with health care was assessed by asking the patients the extent to which they agreed with the following statement: 'I am satisfied with the medical care I receive' (ranging 1-5, with 5 indicating 'strongly agree' or most satisfied with care). Quality of care was assessed by asking the patients to rate the quality of care they received (ranging 2-10, with 10 indicating highest quality). The number of comorbid conditions was derived from the medical history, adopted and modified from the Medical Outcomes Study (21) . The medical history ascertained presence or absence of 34 medical conditions and six mental conditions. The index of comorbidities, which is simply the sum of all possible conditions, has been evaluated against the Veterans SF-36 and measures of health care utilization (22) .
Patients' self-reported medication compliance included four questions, originally developed and validated by Morisky and colleagues (7). Respondents were asked (i) if they ever forgot to take their medicine, (ii) if they were sometimes careless about taking their medicine, (iii) if they sometimes felt well and stopped taking their medicine and (iv) if they sometimes stopped taking medicine because they felt worse. Each item contained a dichotomous response in which a 'yes' category (0) was used to contrast with a 'no' category (1). An overall scale of self-reported compliance was calculated using the unweighted sum of the four items, which yielded a range 0-4, with higher scores denoting higher compliance.
Perceived amount of prescribed medications was measured by asking the patients to indicate, on a three-point scale ('too much', 'right amount', and 'too little'), 'how do they feel about the amount of medicine that is currently prescribed to them' (23) . Involvement in treatment decisions was assessed by asking the patients the extent to which they agreed with the following statement: 'I like to have a say in treatment decisions about my medical care', with a range 1-5, with higher scores indicating more agreement or wanting more involvement in treatment decisions.
Medication database
A pharmacy database was developed by extracting prescription data from databases located at individual VA facilities. The developed pharmacy database was based upon medication prescriptions, refills or partial refills, and provider information on the dispense date, prescription number, the national drug file name, and VA class. This medication database has been previously found to be highly reliable (24) .
Medication data were merged, based on patient identification number, with the VHS files. This database included a total of 44 935 records (prescriptions) provided to patients in the VHS study over a 2-year time period from April 1, 1996, to April 1, 1998 , in which a complete set of medication data was available.
From the VA centralized pharmacies, we obtained information about the number of different medications a patient was taking during the 2-year study period, another variable which has been found to influence compliance with prescribed medication by the patients (25) . We also obtained selected physician characteristics including age, gender, medical school attended (U.S. vs. non-U.S.), year of graduation, type of practice (primary care residents, primary care attending physicians, speciality care residents, speciality care attending physicians, and other health care providers).
Based on a 2-year time window from April, 1996, to April, 1998, we have complete pharmacy data for 1292 patients, who took antihypertensive medications. Matching physician level data with the patients included in the study, we identified 656 physicians who prescribed antihypertensive agents to the patients included in the analysis.
Development of a compliance measure
By our definition, compliance refers to adherence to provider directions by the patient about prescribed medication regimens. There are several ways to measure different domains of compliance. However, there are no gold-standard measures of compliance and all are subject to methodological strengths and weaknesses (6) . Direct measures including physiologic markers are costly and obtrusive. Indirect measures including pill counts have the advantage of measuring errors in dosage and timing, but they are troublesome to monitor. Self-report can measure almost all domains of compliance, but it is often inaccurate with major recall problems. The use of centralized pharmacy records, though not suitable for measuring nonprescription medications, is attractive when available within integrated care systems for ambulatory care patient populations. In an era of managed care, more patients are now enrolled in plans with centralized pharmacies including mail order. The use of computer based assessments with prescriptions and refills is thus appropriate in this environment.
Steiner reported the utility of compliance measures for pharmacy records in the context of the VA (26) , where medications are prescribed through a system of centralized pharmacies. Compliance indicators were derived from two facilities in the VA. The results of pharmacy based adherence measures were validated through comparisons with measures of drug presence and drug effect. Measures were clinically validated in patients with hypertension (blood pressure control). More recently, Christensen and colleagues examined the feasibility and usefulness of prescription refills from computer-based pharmacy records in two clinics in a managed care organization and found that 16% of patients were under-compliant (filled less scripts than were prescribed) (8) .
Following the approach of Steiner and Christensen (8, 26) , we developed a measure of compliance using the prescription (fills and refills) database to describe the level of patient adherence and non-adherence within the VA. For each prescription, the medication database contained the medication name, the VA classification code, issue and dispense dates, and the names of the prescribing health providers.
Compliance rates were computed taking the ratio of the sum of days of supply of any antihypertensive medications dispensed to the patient (excluding the supply days of the last dispense) to the sum of the elapsed intervals between the last dispense date and the first issue date. In this formula, the numerator indicates the actual number of days of antihypertensive medications dispensed or supplied to the patient, whereas the denominator indicates the number of days of antihypertensive medications a patient is supposed to take as issued by the health provider. Based on the assumption that a patient cannot be compliant when he has not obtained sufficient medications, a compliance ratio of <1 (one being perfectly compliant) will indicate a gradual deviation from being perfectly compliant, or under-compliant.
Analytical strategy
We first presented patient and physician characteristics. Then, we presented descriptive statistics of the compliance measure by categorizing patients into two groups based on their compliance scores: undercompliant (with scores <0AE8) and compliant (with scores ‡0AE8) (8) . To evaluate our compliance measure based on pharmacy data, we conducted Pearson's product moment correlation between the compliance measure and patient self-reported compliance. The compliance measure was also evaluated by examining its relationship with self-perceived amount of prescribed medications by the patients.
To examine the relationship between our compliance measure with selected patient characteristics (e.g. age, education, marital status, race, number of medications, number of comorbid conditions, physical health, mental health, satisfaction with care, and propensity to participate in treatment decisions) and physician characteristics (e.g. age, gender, place of medical education, year of graduation from medical school, and types of practices), we first conducted bivariate analyses. Then, to ascertain the relative contribution of selected patient or physician characteristics in explaining the variability of compliance, we conducted three separate sets of ordinary least squares regression models, one for patient characteristics, one for physician characteristics, and one combining patient and physician characteristics. These multiple regression analyses were conducted using a P-value of <0AE2 as the inclusion criteria.
R ES U L T S
About 61% of the patients included in the study were over 65 years of age with a mean of 65 years (SD ¼ 10) of age ( Table 1) . Among the study patients, 63AE7% of received £12 years of education, 60% were married, and 91AE9% were white. The study patients had an average of about seven comorbid conditions and took about three types of medications per month within the 2-year study period.
Health providers, who prescribed antihypertensive medications to patients included in the study, had an average age of 45 years (SD ¼ 13) (Table 2) , were predominantly male (65AE8%), were trained in the U.S. (80AE4%), and wrote prescriptions to 14 patients on average. About 24% of them graduated from medical school prior to 1980, 21% between 1980 and 1989, and 55% after 1989. Among the 656 health providers who prescribed antihypertensive medications, 26AE8% were primary care residents, 26AE5% speciality care residents, 14AE3% primary care attending physicians, 18AE2% speciality care attending physicians, and 14AE3% other health care providers.
As shown in Fig. 1 , among 1292 patients who took antihypertensive medications, 72AE8% were compliant and 27AE2% were under-compliant with a compliance score of <0AE8. The prevalence of undercompliance with antihypertensive medications that we observed is quite similar to that reported by Roe and colleagues (29%) (27) , but is somewhat higher than that reported by Christensen and colleagues (17%) (8) .
In examining the association of the compliance measure based on pharmacy data with selfreported compliance and perceived amount of prescribed medications, we found that the compliance measure based on pharmacy data was significantly associated with self-reported compliance [r ¼ 0AE14 (P < 0AE01)] although the magnitude of the correlation is small. This indicates that those who reported more adherence to their medications were also more compliant as measured by prescription data (e.g. obtaining sufficient medications). Similarly, the compliance measure based on pharmacy data showed a monotonic decrease for the three categories of self-perceived amount of prescribed antihypertensive medications. Those who reported 'too much' prescribed medications were least compliant (0AE85), whereas those who reported 'too little' prescribed medications were most compliant (0AE91). Although this gradient was not statistically significant, the trend observed was nonetheless consistent with an earlier study in which Fincke and colleagues reported a 1AE5-2AE0 fold decrease in compliance among those who reported they had been prescribed too much medications (23) .
Patient characteristics and compliance
The analyses focused on selected patient characteristics, which were hypothesized to influence compliance in the literature. First, we examined the univariate relationships between patient characteristics and compliance (as a continuous variable) ( Table 3 ). The results indicated that number of medications was positively associated with compliance (P < 0AE01), suggesting that patients who took more medications were more likely to be compliant than those who took fewer medications. Patients who were more involved in treatment decisions were more compliant than those who were less involved in treatment decisions (P < 0AE01). Model 1 presented in Table 3 included only patients' sociodemographic characteristics (such as age, race, and education), number of medications, and involvement in treatment decision. Number of medications and involvement in treatment decision were two significant predictors of compliance. Both the magnitude and direction of the regression coefficients of these two variables remained similar when the analyses included other variables such as number of medical conditions, SF-36's physical and mental summary health, and rating of the overall quality of life (results not shown).
To explore the extent to which the effect of number of medications on compliance is attributable to age, we conducted additional analyses stratifying age into two groups: those <65 and ‡65 years of age. The results (not shown) indicate that for younger patients (<65 years of age), number of medications, though not significant, had a negative effect; whereas for older patients ( ‡65 years of age), number of medications had a significant, positive effect on compliance (P < 0AE01), suggesting that only older patients ( ‡65 years of age) who took more medications were more likely to be compliant.
Health provider characteristics and compliance
The univariate analyses examining the association between selected health provider characteristics and compliance indicated that physicians' age and male physicians were negatively associated with compliance (P < 0AE001 and 0AE08, respectively), suggesting that patients whose antihypertensives were prescribed by older and male health care providers were less likely to be compliant. Consistent with the finding for age, year of graduation from medical school was also associated with compliance with those who graduated since 1990 having more compliant patients (P < 0AE09). Compared with primary care residents, speciality care residents, primary and speciality care attending physicians tended to have patients who were less likely to be compliant. (P < 0AE01, 0AE01, and 0AE001, respectively). On the other hand, comparing to all physician groups, other health care providers such as nurse practitioners and physician assistants tended to have patients who were more likely to be compliant (P < 0AE01). Model 2 of Table 3 presented multiple regression analyses results. Physicians' age had a negative effect on compliance (P < 0AE001), suggesting that patients whose antihypertensives were prescribed by older health care providers were less likely to be compliant. Compared with primary care residents, speciality care residents tended to have patients who were significantly less likely to be compliant (P < 0AE01); whereas primary and speciality care attending physicians tended to have patients who were less likely to be compliant, though statistically not significant. On the other hand, compared with all physician groups, other health care providers (e.g. physician assistants and nurse practitioners) tended to have patients who were more likely to be compliant (P ¼ 0AE08). Because physicians' age and year of graduation was highly associated (r ¼ )0AE92, P < 0AE001), the multiple regression model (2) did not include year of graduation. However, in a separate multiple regression model substituting age by year of graduation, the effect of year of graduation on compliance was not significant (results not shown).
Combined patient and health provider variables as predictors of compliance
Model 3 of Table 3 presented results that explored the relative contribution of patients' and health providers' characteristics to patients' compliance. Consistent with Model 1, number of medications and treatment decision had significant, positive effects on compliance with antihypertensives after adjusting for both patients' and physicians' characteristics (P < 0AE01 and 0AE05, respectively), suggesting that patients who took more medications or were more involved in treatment decisions were more compliant. After adjustment, patients' age had a significant, positive effect on compliance (P < 0AE05), suggesting that older patients were more likely to be compliant.
Consistent with Model 2, physicians who were older or specialty care residents had significant, negative effects on compliance after adjusting for both patients' and physicians' characteristics (P < 0AE01 and 0AE01, respectively), suggesting that patients whose antihypertensives were prescribed by older providers or by speciality care residents were less likely to be compliant. On the other hand, after adjusting for both patients' and physicians' characteristics, non-physicians tended to have patients who were more likely to be compliant (P < 0AE03) than physicians.
DISCUSSION
In this study, following previous approaches (8, 26) , we have developed an algorithm for a compliance measure based on pharmacy data (or prescription fills and refills) to describe the level of patient adherence and non-adherence for antihypertensives within the VA. This measure of compliance was corroborated with patient selfreported compliance, indicating that patients who reported being careless or forgetful about taking their medications tended to be less likely to obtain sufficient medications as reflected in the pharmacy data. The veterans enrolled in the VA are entitled to medications with a $2AE00 copayment arrangement. The economic incentive for veterans is almost always to obtain medications through VA medical centres rather than from other systems of care. Unlike many other health insurance plans where subscribers can obtain medications through a variety of sources (e.g. pharmacy chains), veterans will obtain their initial medication prescriptions and refills through the VA centralized pharmacies. This system thus allows for tracking medication compliance using prescription refills, whereas in other civilian systems this might be extremely difficult given multiple sources for obtaining initial and refill prescriptions.
In determining factors associated with patient compliance, we have identified several patients' characteristics that had significant associations with compliance. First, the effect of number of medications corroborated the findings in the literature, that is, patients who required more medications tended to believe themselves in need of treatment and therefore were more likely to be compliant (10) . A close examination also suggested that number of medications had a significant, positive effect on compliance only among patients who were ‡65 years of age. This age effect on compliance was also supported by a significant, positive effect of patients' age on compliance. Second, patients who were proactive in their treatment decisions tended to be more compliant with antihypertensives, a finding which is consistent with previous studies in which doctor-patient communication was found to enhance adherence to medications (28) . Third, unlike other studies (20, 29) , our study did not find any significant effects on compliance for race, education attainment, satisfaction with care, and number of comorbid conditions.
In determining factors associated with patient compliance, we have also identified some important relationships between health provider characteristics and compliance. Although the role of physicians' age in patients' compliance with medications is equivocal in the literature (11), our study indicated that health care providers' age had a significant, negative effect on compliance, suggesting that patients whose antihypertensives were prescribed by older health care providers were less likely to be compliant than those antihypertensives were prescribed by younger health care providers. This result warrants further investigation into treatment and communication styles between older and younger doctors in dealing with patients.
Patients whose prescriptions were written by 'specialists', especially speciality care residents, were less compliant compared with those whose prescriptions were written by primary care residents. This finding is consistent with previous studies which reported that adherence rates tended to vary considerably among types of practice (11, 30) . The finding suggests that compared with primary care residents, speciality care doctors may be less likely to see the patient on a regular basis. On the other hand, nurse practitioners and physician assistants tend to spend more time with patients and therefore have patients who are more compliant than physicians. In light of the finding in the literature that more physician visits were associated with better patient compliance (25) , the findings of our study imply that future research should ascertain if continuity of care (e.g. number of times seen by the same provider) would offer any explanations to the association between physicians' speciality and patients' compliance.
Ely and colleagues reported that female physicians tended to have more compliant patients because female physicians tended to spend more time with patients and were more attentive and accepting of patients' feelings (12) . However, this result was not corroborated by our study, in which we found no significant effects of gender on compliance with antihypertensives.
It is important to note three limitations of the study. First, while the incentive to obtain medications in the VA is great because of an inexpensive $2AE00 copay arrangement for each medication, it is possible that some VA users may obtain their medications from other non-VA sources. Second, the 'specialists' (i.e. speciality care residents and speciality care attending physicians) in the study are not necessarily physicians who work in the speciality clinics for the specific diseases included in the study; instead they are a lumping together of all 'other' specialities (other than those in internal medicine, general preventive medicine, and family practice). It is possible that patient compliance may vary across different types of 'specialists', particularly when considering the speciality related to the indication for the specific medication under study. Because of small sample sizes of each category of 'specialists', the present study was not able to examine these differences. Third, DiMatteo and colleagues reported that physicians who saw more patients per week, an indication of possible more visits by the patients to check up on medication taking, tended to have more compliant patients (11) . However, in this study we found no significant effects of the number of patients on compliance with antihypertensives. It is possible that the study did not consider the total number of patients in physician practice; instead, it merely considered patients who were included in the Veterans Health Study as well as on antihypertensive medications.
Despite these shortcomings, the results of study suggest that the pharmacy records within the VA can provide an algorithm to assess compliance. The prospect of using this algorithm is particularly important for monitoring the progress of patients with chronic diseases within the VA. The results of our study indicate that despite the importance of medication compliance to the clinical management of chronic diseases (6) (7) (8) , non-compliance with antihypertensives is still widespread, especially among elderly patients, within the VA. To increase the effectiveness of medical care and reduce unnecessary medical expenses, it is important for the VA to study factors that influence compliance or non-compliance with antihypertensives. For research purposes, an understanding of the patterns of compliance by patient and physician characteristics is clearly useful in the context of therapeutic efficacy and effectiveness studies. Clinical trials need to consider the impact of non-compliance on the therapeutic effect measured which may influence the power of the study. For effectiveness studies or post marketing surveillance work, noncompliance may influence the impact of medications on outcomes, including symptoms, clinical endpoints and health related quality of life.
The results of this study indicate the potential importance of selected physician characteristics as they relate to compliance with antihypertensives. For example, the study revealed that physicians' speciality and type of practice were associated with patient compliance. These results raise some important issues for future exploration. The nature of the doctor-patient relationship and perhaps the style of the physicians' approach to rendering care might explain some of the differences in patient compliance results. The continuity of care and patient access to the provider may also explain some of these differences. The differing approaches to the care process by physicians who are in training vs. more senior physicians (e.g. residents vs. attendings) and those who are in primary care vs. speciality care settings contribute to some of these differences in compliance.
